Abstract
“I think there are tremendous parallels to the early days of recombinant DNA in this field,” says James Thomson, director of Regenerative Biology at the Morgridge Institute for Research in Madison, Wisconsin, and one of the founders of Cellular Dynamics International, also in Madison.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguilar Hernández R, Sánchez De Las Matas MJ, Arriagada C, Barcia C, Caviedes P, Herrero MT, Segura-Aguilar J (2003) MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity. Neurotox Res 5(6):407–410
Andrews PW, Meyer LJ, Bednarz KL, Harris H (1984) Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 3(1):33–39
Arriagada R, Le Péchoux C, Baeza MR (2003) Prophylactic cranial irradiation in high-risk non-small cell lung cancer patients. Lung Cancer 42(Suppl 2):S41–S45
Augusti-Tocco G, Sato G (1969) Establishment of functional clonal lines of neurons from mouse neuroblastoma. Proc Natl Acad Sci U S A 64(1):311–315
Allen DD et al (2005). Cell lines as in vitro models for drug screening and toxicity studies. Drug Dev Ind Pharm 31(8):757–768
Arima M, Plitt J, Stellato C, Bickel C, Motojima S, Makino S, Fukuda T, Schleimer RP (1999) Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone. Am J Respir Cell Mol Biol 21(6):684–692
Blaineau C, Connan F, Arnaud D, Andrews P, Williams L, McIlhinney J, Avner P (1984) Definition of three species-specific monoclonal antibodies recognizing antigenic structures present on human embryonal carcinoma cells which undergo modulation during in vitro differentiation. Int J Cancer 34(4):487–494
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR (1998) Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149(2):310–321
Brandt BL, Kimes BW, Klier FG (1976) Development of a clonal myogenic cell line with unusual biochemical properties. J Cell Physiol 88(3):255–275
Cárdenas AM, Arriagada C, Allen DD, Caviedes R, Cortes JF, Martin J, Couve E, Rapoport SI, Shimahara T, Caviedes P (2002a) Cell lines derived from hippocampal neurons of the normal and trisomy 16 mouse fetus (a model for Down syndrome) exhibit neuronal markers, cholinergic function, and functional neurotransmitter receptors. Exp Neurol 177(1):159–170
Cárdenas AM, Allen DD, Arriagada C, Olivares A, Bennett LB, Caviedes R, Dagnino-Subiabre A, Mendoza IE, Segura-Aguilar J, Rapoport SI, Caviedes P (2002b) Establishment and characterization of immortalized neuronal cell lines derived from the spinal cord of normal and trisomy 16 fetal mice, an animal model of Down syndrome. J Neurosci Res 68(1):46–58
Castro P, Arriagada G, Moreno M, Morán S, Becker P, Zalaquett R, Godoy I, Córdova S (2000) Humoral rejection in heart transplantation. Report of 2 cases. Rev Med Chil 128(11):1245–1249
Caviedes R, Liberona JL, Hidalgo J, Tascon S, Salas K, Jaimovich E (1992) A human skeletal muscle cell line obtained from an adult donor. Biochim Biophys Acta 1134(3):247–255
Caviedes P, Olivares E, Salas K, Jaimovich E (1993) Calcium fluxes, ion currents and dihydropyridine receptors in a new immortal cell line from rat heart muscle. J Mol Cell Cardiol 25(7):829–845
Cressey D (2012) Stem cells take root in drug development. Nature. doi:10.1038/Nature.2012.10713 (News article)
Davila JC et al (2004) Use and application of stem cells in toxicology. Toxicol Sci 79:214–233
Fields C, Cassano A, Makhoul RG, Allen C, Sims R, Bulgrin J, Meyer A, Bowlin GL, Rittgers SE (2002) Evaluation of electrostatically endothelial cell seeded expanded polytetrafluoroethylene grafts in a canine femoral artery model. J Biomater Appl 17(2):135–152
Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU, Snyder EY (1998) Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16(11):1033–1039
Frederiksen K, Thorpe A, Richards SJ, Waters J, Dunnett SB, Sandberg BE (1996) Immortalized neural cells from trisomy 16 mice as models for Alzheimer’s disease. Ann N Y Acad Sci 777:415–420
Hall BM, Fortney JE, Taylor L, Wood H, Wang L, Adams S, Davis S, Gibson LF (2004) Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells. Cancer Lett 207(2):229–239
Horton PJ, Hawthorne WJ, Walters SN, Patel AT, O’Connell PJ, Chapman JR, Allen RD (2000) Induction of allogeneic islet tolerance in a large-animal model. Cell Transplant 9(6):877–887
Juchau MR, Krasner J, Yaffe SJ (1968) Studies on reduction of azo-linkages in human placental homogenates. Biochem Pharmacol 17(9):1969–1979, No abstract available
Kerin JF, Jeffrey R, Warnes GM, Cox LW, Broom TJ (1981) A simple technique for human embryo transfer into the uterus. Lancet 2(8249):726–727
Kim JH, Hammond DN (1995) Septal cell lines derived from the trisomy 16 mouse: generation, characterization, and response to NGF. Brain Res 671(2):299–304
Li AP (2001) Screening for human ADME/Tox drug properties in drug discovery. Res Focus 6(7):357–366, DDT
Liberona JL, Caviedes P, Tascón S, Hidalgo J, Giglio JR, Sampaio SV, Caviedes R, Jaimovich E (1997) Expression of ion channels during differentiation of a human skeletal muscle cell line. J Muscle Res Cell Motil 18(5):587–598
Liberona JL, Powell JA, Shenoi S, Petherbridge L, Caviedes R, Jaimovich E (1998) Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines. Muscle Nerve 21(7):902–909
Maury Y et al (2011) Human pluripotent stem cells for disease modeling and drug screen. Bioessays 34:61–71
Plendl J, Sinowatz F, Auerbach R (1995) A transformed murine myocardial vascular endothelial cell clone: characterization of cells in vitro and of tumours derived from clone in situ. Virchows Arch 426(6):619–628
Rubin LL (2008) Stem cells and drug discovery: the beginning of a new era? Cell 132:549–552
Sinz MW, Kim S (2006) Stem cells, immortalized cells and primary cells in ADMET assays. Drug Discov Today Technol| ADMET Technol 3(1):79–85
Sipido KR, Marban E (1991) L-type calcium channels, potassium channels, and novel nonspecific cation channels in a clonal muscle cell line derived from embryonic rat ventricle. Circ Res 69(6):1487–1499
Turner JA, Cardenas DD (1999) Chronic pain problems in individuals with spinal cord injuries. Semin Clin Neuropsychiatry 4(3):186–194
Villas C, Arriagada C, Noain E, Beguiristain JL, Bascuñan F (1998) Surgical treatment of vertebral metastasis. Rev Med Univ Navarra 42(4):188–193
Wobus AM, Wallukat G, Hescheler J (1991) Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48(3):173–182
Yaffe D, Saxel O (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270(5639):725–727
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer India
About this chapter
Cite this chapter
Ray Banerjee, E. (2014). Use of Stem Cells in Drug Screening. In: Perspectives in Regenerative Medicine. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2053-4_3
Download citation
DOI: https://doi.org/10.1007/978-81-322-2053-4_3
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2052-7
Online ISBN: 978-81-322-2053-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)